Melanoma patients receiving autologous DCs electroporated with mRNAs encoding MAGE-A1, -A3, -C2, tyrosinase, MelanA/MART-1, or gp100, show DC-related adverse events but no appreciable toxicity [93]. Here, PMEL is linked to melanoma.